ABSTRACT

After completion of surgical and oncological primary treatment of cancers, the effect of lymphadenectomy on patients’ survival is controversial in patients with giant lymphadenopathy which is the first sign of cancer recurrence. In this retrospective study we aimed to evaluate our treatment modalities and effect of surgery to survival in four patients with cancer relapse with giant inguinal and axillary lymphadenopathy.

The survey of the cases are evaluated via radiological and clinic datas after exicision of metastatic giant lympadenopathy and after termination of postoperative oncological therapy.

Due to giant lympadenopathy, region 1-2-3 axillary lymp node dissection to one patient and expanded inguinal lymph node dissection to three other patient were performed. The pathology of dissection material was matched with the primary tumor metastase. Oncologic therapy sessions were started in postoperative period. During 20 months follow-up of the cases there was not any recurrence or metastasis.

In the cases that were evaluated after giant metastatic lymph node involvement, we assessed primary tumor type, clinical course as well as survival after surgical procedures that we performed for lymph node involvement. The survey is evaluated after clinical follow-up and primary tumor type with the surgery performed for lymph node invasion within the cases we evaluate after giant metastatic lymph node invasion. Although it’s been said that there isn’t any specific contribution to average 5 year survival it raises hope that there wasn’t any recurrence during the follow-ups.